CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Begg, C. B.
Right arrow Articles by Zhang, Z. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Begg, C. B.
Right arrow Articles by Zhang, Z. F.

Cancer Epidemiology Biomarkers & Prevention, Vol 3, Issue 2 173-175, Copyright © 1994 by American Association for Cancer Research


ARTICLES

Statistical analysis of molecular epidemiology studies employing case-series

CB Begg and ZF Zhang
Memorial Sloan-Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, New York 10021.

The case-series design is being used increasingly to explore associations between environmental risk factors and genetic markers. It is demonstrated that the odds ratio derived from a case-series study is the ratio of the relative risk for developing marker-positive disease to the relative risk for developing marker-negative disease. This parameter is an empirical manifestation of etiological heterogeneity with respect to the risk factor under study, and it can be used to construct a statistical significance test. Presence of etiological heterogeneity, as reflected in departures of this parameter from unity, could be a result of either the presence of distinct causal mechanisms for the two categories of cases, or a different strength of effect via the same mechanism. The case-series approach represents an efficient and valid approach for evaluating gene-environment associations, especially in referral centers where it is difficult to identify a valid control group.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. E. Thomas, S. N. Edmiston, A. Alexander, R. C. Millikan, P. A. Groben, H. Hao, D. Tolbert, M. Berwick, K. Busam, C. B. Begg, et al.
Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 991 - 997.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. M. Chiarelli, V. A. Kirsh, N. S. Klar, R. Shumak, R. Jong, E. Fishell, M. J. Yaffe, and N. F. Boyd
Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1856 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. E Kelemen, J. R Cerhan, U. Lim, S. Davis, W. Cozen, M. Schenk, J. Colt, P. Hartge, and M. H Ward
Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study
Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1401 - 1410.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
U. Lim, M. Schenk, L. E. Kelemen, S. Davis, W. Cozen, P. Hartge, M. H. Ward, and R. Stolzenberg-Solomon
Dietary Determinants of One-Carbon Metabolism and the Risk of Non-Hodgkin's Lymphoma: NCI-SEER Case-Control Study, 1998-2000
Am. J. Epidemiol., November 15, 2005; 162(10): 953 - 964.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. R. Brooks, J. H.M. Austin, R. T. Heelan, M. S. Ginsberg, V. Shin, S. H. Olson, J. E. Muscat, and S. D. Stellman
Influence of Type of Cigarette on Peripheral versus Central Lung Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 576 - 581.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
R. M. Tamimi, S. E. Hankinson, H. Campos, D. Spiegelman, S. Zhang, G. A. Colditz, W. C. Willett, and D. J. Hunter
Plasma Carotenoids, Retinol, and Tocopherols and Risk of Breast Cancer
Am. J. Epidemiol., January 15, 2005; 161(2): 153 - 160.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Rundle
Molecular Epidemiology of Physical Activity and Cancer
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 227 - 236.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
I. J. Hall, P. G. Moorman, R. C. Millikan, and B. Newman
Comparative Analysis of Breast Cancer Risk Factors among African-American Women and White Women
Am. J. Epidemiol., January 1, 2005; 161(1): 40 - 51.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. L. Freudenheim, M. Bonner, S. Krishnan, C. B. Ambrosone, S. Graham, S. E. McCann, K. B. Moysich, E. Bowman, T. Nemoto, and P. G. Shields
Diet and alcohol consumption in relation to p53 mutations in breast tumors
Carcinogenesis, June 1, 2004; 25(6): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Koushik, R. W. Platt, and E. L. Franco
p53 Codon 72 Polymorphism and Cervical Neoplasia: A Meta-Analysis Review
Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 11 - 22.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Furberg, R. C. Millikan, J. Geradts, M. D. Gammon, L. G. Dressler, C. B. Ambrosone, and B. Newman
Environmental Factors in Relation to Breast Cancer Characterized by p53 Protein Expression
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 829 - 835.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. S. Engel, E. Taioli, R. Pfeiffer, M. Garcia-Closas, P. M. Marcus, Q. Lan, P. Boffetta, P. Vineis, H. Autrup, D. A. Bell, et al.
Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review
Am. J. Epidemiol., July 15, 2002; 156(2): 95 - 109.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
N T Brockton
UGT1A1 polymorphisms and colorectal cancer susceptibility
Gut, June 1, 2002; 50(6): 748 - 749.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. C. Schroeder and C. R. Weinberg
Use of Missing-Data Methods to Correct Bias and Improve Precision in Case-Control Studies in which Cases Are Subtyped but Subtype Information Is Incomplete
Am. J. Epidemiol., November 15, 2001; 154(10): 954 - 962.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. M. Basham, P. D.P. Pharoah, Catherine.S. Healey, R. N. Luben, N. E. Day, D. F. Easton, B. A.J. Ponder, and A. M. Dunning
Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk
Carcinogenesis, November 1, 2001; 22(11): 1797 - 1800.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. E. Mitchell, J. C. Murray, S. O'Brien, and K. Christensen
Evaluation of Two Putative Susceptibility Loci for Oral Clefts in the Danish Population
Am. J. Epidemiol., May 15, 2001; 153(10): 1007 - 1015.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. D. Botto and M. J. Khoury
Commentary: Facing the Challenge of Gene-Environment Interaction: The Two-by-Four Table and Beyond
Am. J. Epidemiol., May 15, 2001; 153(10): 1016 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. B. Thomas, Q. Qin, J. Kuypers, N. Kiviat, R. L. Ashley, A. Koetsawang, R. M. Ray, and S. Koetsawang
Human Papillomaviruses and Cervical Cancer in Bangkok. II. Risk Factors for in Situ and Invasive Squamous Cell Cervical Carcinomas
Am. J. Epidemiol., April 15, 2001; 153(8): 732 - 739.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. A. Levine and J. Boyd
The Androgen Receptor and Genetic Susceptibility to Ovarian Cancer: Results from a Case Series
Cancer Res., February 1, 2001; 61(3): 908 - 911.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
M. Orjuela, V. P. Castaneda, C. Ridaura, E. Lecona, C. Leal, D. H. Abramson, I. Orlow, W. Gerald, and C. Cordon-Cardo
Presence of Human Papilloma Virus in Tumor Tissue from Children with Retinoblastoma: An Alternative Mechanism for Tumor Development
Clin. Cancer Res., October 1, 2000; 6(10): 4010 - 4016.
[Abstract] [Full Text]


Home page
J. Epidemiol. Community HealthHome page
H. E KUPER, L. A MUCCI, and D. TRICHOPOULOS
Coffee, pancreatic cancer and the question of causation
J. Epidemiol. Community Health, September 1, 2000; 54(9): 650 - 651.
[Full Text]


Home page
J. Epidemiol. Community HealthHome page
B. K JACOBSEN and I. HEUCH
Coffee, K-ras mutations and pancreatic cancer: A heterogeneous aetiology or an artefact?
J. Epidemiol. Community Health, September 1, 2000; 54(9): 654 - 655.
[Full Text]


Home page
JNCI J Natl Cancer InstHome page
M. L. Gillison, W. M. Koch, R. B. Capone, M. Spafford, W. H. Westra, L. Wu, M. L. Zahurak, R. W. Daniel, M. Viglione, D. E. Symer, et al.
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
J Natl Cancer Inst, May 3, 2000; 92(9): 709 - 720.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. M. Marcus, R. B. Hayes, P. Vineis, M. Garcia-Closas, N. E. Caporaso, H. Autrup, R. A. Branch, J. Brockmöller, T. Ishizaki, A. E. Karakaya, et al.
Cigarette Smoking, N-Acetyltransferase 2 Acetylation Status, and Bladder Cancer Risk: A Case-Series Meta-analysis of a Gene-Environment Interaction
Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 461 - 467.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
E. Kampman, D.W. Voskuil, A.A. van Kraats, H.F. Balder, G.N.P. van Muijen, R.A. Goldbohm, and P. van't Veer
Animal products and K-ras codon 12 and 13 mutations in colon carcinomas
Carcinogenesis, February 1, 2000; 21(2): 307 - 309.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W.-Y. Huang, B. Newman, R. C. Millikan, K. Conway, B. S. Hulka, M. J. Schell, and E. T. Liu
Risk of Breast Cancer According to the Status of HER-2/neu Oncogene Amplification
Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 65 - 71.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
S.-M. Hou, D. Ryberg, S. Falt, A. Deverill, T. Tefre, A.-L. Borresen, A. Haugen, and B. Lambert
GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients
Carcinogenesis, January 1, 2000; 21(1): 49 - 54.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
A. M. Goldstein and N. Andrieu
Detection of Interaction Involving Identified Genes: Available Study Designs
J Natl Cancer Inst Monographs, December 1, 1999; 1999(26): 49 - 54.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Yngveson, C. Williams, A. Hjerpe, J. Lundeberg, P. Söderkvist, and G. Pershagen
p53 Mutations in Lung Cancer Associated with Residential Radon Exposure
Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 433 - 438.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.